Kim, Seung Tae <br/><br/>
Selection of a patient subgroup with advanced esophageal squamous carcinoma who could benefit from second-line chemotherapy.  [electronic resource] 

 -  Oncology  2010 
 - 363-9 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1423-0232 
<br/><br/><label>Standard No.: </label>10.1159/000322498  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Carcinoma, Squamous Cell--drug therapy<br/>Cisplatin--therapeutic use<br/>Disease-Free Survival<br/>Esophageal Neoplasms--drug therapy<br/>Female<br/>Humans<br/>Kaplan-Meier Estimate<br/>Male<br/>Middle Aged<br/>Patient Selection<br/>Prognosis<br/>Retrospective Studies<br/>Salvage Therapy<br/>Treatment Outcome